PMC6409020_01
(a) Distinct oedema of the cervical spinal cord on T2-weighted sequences with spinal cord swelling and expansion into the brainstem. (b) Distinct gadolinium enhancement of the cervical spinal cord on T1-weighted sequences with cord swelling. (c) Regressive edema in the cervical spinal cord after 5 days of methylprednisolone followed by plasmapheresis and immunoadsorption. (d) Regressive gadolinium enhancement in the cervical spinal cord after therapy.
CRINM2019-9691863.001.jpg
PMC6409020_01_CRINM2019-9691863.001.jpg
fig1
The cervical MRI then revealed the full extent of the cervical myelitis over more than three vertebral segments (see Figures 1(a) and 1(b)). Under initial high-dose treatment with methylprednisolone, followed by plasmapheresis and immunoadsorption, clinical symptoms of ataxia and hypesthesia and the spinal cord enhancement on MRI were regressive within 10 days (see Figures 1(c) and 1(d)).